Malecare

Malecare is dedicated to providing support and resources for individuals affected by prostate cancer and male breast cancer, particularly addressing the unique challenges faced by LGBTQ+ individuals. The organization focuses on advocacy, education, and community support to improve the quality of life for patients and their families. Additionally, it aims to increase clinical trial participation through initiatives like the Pathfinder Clinical Trial Tax Credit Act, which aims to reduce financial barriers for patients. Malecare is a leading prostate cancer nonprofit organization and the most respected prostate cancer patient advocacy group globally. Founded in 1998, Malecare has grown into America’s first, largest, and foremost men’s cancer support and advocacy nonprofit. It is internationally recognized for pioneering patient-centered programs that improve community impact, advance patient advocacy, and support minority healthcare needs. Malecare’s 501(c)(3) status and professional leadership (oncologists, psychologists, and social workers) ensure a highly effective, data-driven approach that corporate partners can trust. Guided by a mission to help men live longer and happier lives, Malecare delivers measurable outcomes in prostate cancer awareness, patient survival, and quality of life, aligning with corporate social responsibility goals of health equity and impact. Malecare’s Prostate Cancer Newsletter pulls doctor and industry-based news from leading cancer centers, journals, and conferences. It focuses on advanced-stage prostate cancer and provides tailored solutions to subscribers.